CCL4 and melanoma: Besides, tumor-infiltrating granulocytes and monocellular myeloid-derived suppressor cells can release CCL4 in surplus to act on CCR5 receptors on melanoma and lymphoma cancer cells, thus recruiting a large number of T regulatory cells and promoting the generation, growth, and metastasis of cancer (25).